By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pfenex Inc. 

5501 Oberlin Drive

San Diego  California  92121  U.S.A.
Phone: 858-352-4400 Fax: 858-352-4602



Company News
Pfenex (PFNX) Announces Early HSR Clearance For Collaboration With Hospira 3/23/2015 9:05:19 AM
Pfenex (PFNX) Reports Fourth Quarter And Full Year 2014 Results And Provides Business Update 3/16/2015 9:53:16 AM
Pfenex (PFNX) Exercises Glide Contract Extension For Solid Dose Formulation Of Recombinant Protective Antigen (rPA)-Based Anthrax Vaccine 3/9/2015 9:32:38 AM
Pfenex (PFNX) To Report Fourth Quarter And Full Year 2014 Results And Provide Business Update 3/6/2015 6:59:22 AM
Pfenex (PFNX)To Present At The 2015 Barclays Global Healthcare Conference 3/2/2015 9:13:14 AM
Pfenex (PFNX) To Present At CALBIO 2015 2/27/2015 10:12:00 AM
Pfenex (PFNX) To Present At The 2015 RBC Capital Markets' Healthcare Conference 2/13/2015 7:50:49 AM
Pfenex (PFNX), Hospira Pursue Lucentis Biosimilar in $342 Million Pact 2/10/2015 11:29:09 AM
Pfenex Inc. (PFNX) To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO And Investor Conference 1/29/2015 11:59:03 AM
Pfenex Inc. (PFNX) Announces Active IND And Additional BARDA Funding For Recombinant Anthrax Vaccine Program, Px563L 12/22/2014 8:12:39 AM